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Summary
The data presented in this paper describe trends in treated problem drug use in Ireland.
The total numbers include 33,391 cases who lived and were treated in Ireland between
1998 and 2002. In this paper, treated problem drug use is described in relation to
person, place and time. This paper will assist policy makers, service planners and public
health practitioners to develop appropriate responses to problem drug use in the future. 
The analysis presented in this paper is based on data reported to the National Drug
Treatment Reporting System.
The main findings and their implications are: 
• The prevalence of treated problem drug use among persons aged between 15 and
64 years living in Ireland, expressed per 100,000 of the population, increased by 27
per cent, from 225.4 in 1998 to 286.9 in 2002. The increased prevalence of treated
problem drug use indicates that problem drug use is a chronic health condition that
requires repeated treatment over time. 
• The incidence of treated problem drug use among persons aged between 15 and 64
years living in Ireland, expressed per 100,000 of the population, increased by 24 per
cent, from 59.0 in 1998 to 73.3 in 2001, and subsequently decreased by 6 per cent
in 2002. The decreased incidence observed in 2002 masks two separate trends. The
first trend observed is that the incidence of treated problem drug use in the areas
outside the Health Service Executive Eastern Region (Dublin, Kildare and Wicklow)
almost trebled, from 24.8 per 100,000 of the population in 1998 to 69.7 per
100,000 in 2002 (Long et al. 2004). The second trend is a decrease in the incidence
of treated problem drug use (specifically opiates) in Dublin between 2000 and 2002
(Kelly et al. 2005). The decrease in the incidence of treated problem opiate use may
reflect a decrease in new opiate users in Dublin, saturation of the more vulnerable
populations in Dublin, a switch to other drugs (such as cocaine), a combination of
these factors, or another factor not yet identified. The most likely explanation is a
decrease in new opiate users in certain areas of Dublin and, to a lesser extent, a
switch to other drugs by young people in Dublin.
• The incidence rates of treated problem drug use among persons aged between 
15 and 64 years living in Ireland, expressed per 100,000 of the population, was
examined by county for the period 1998 to 2002. The incidence rates were highest
in Carlow, Dublin and Waterford (with over 100 cases per 100,000 of the 15 to 64
year old population), followed by Cork, Louth, Meath, Westmeath, Sligo, Tipperary
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and Limerick (with between 50 and 99 cases per 100,000). Excluding Sligo, the incidence rates were lowest
in western counties (with between 10 and 19 cases per 100,000). 
• During the reporting period, opiates were the most frequently reported main problem drug, while cannabis
was the second most frequently reported main problem drug by treated cases in Ireland. The pattern of
main problem drugs reported by cases previously treated was similar to that reported by all cases, while the
pattern reported by new cases was different. The number of new cases treated who reported problem
opiate use decreased by 21 per cent, from a peak of 922 in 1999 to 729 in 2002. The number of new cases
treated who reported problem cannabis use increased by 144 per cent, from 379 in 1998 to 925 in 2002.
The numbers of new cases treated who reported cocaine as their main problem drug, though small,
increased consistently between 1999 and 2002. 
• The types of main problem drug reported by new cases differed by Health Service Executive (HSE) area. In
the HSE Northern (Dublin), HSE East Coast, HSE South Western, HSE North Eastern and HSE Midland Areas,
opiates and cannabis were the most common main problem drugs reported by new treated cases. In the
HSE South, HSE South Eastern and HSE Western Areas, cannabis and ecstasy were the most common main
problem drugs reported by new cases. This may reflect either the types of drug used or the types of
treatment service provided in the area, or a combination of both factors. 
• Of all cases treated between 1998 and 2002, 28 per cent reported problem use of one drug, 32 per cent
reported problem use of two drugs, 26 per cent reported problems with three drugs and 15 per cent
reported problems with four or more drugs. The proportion of cases treated who reported problems with
more than one drug increased by 5 per cent, from 71 per cent in 1998 to 76 per cent in 2002. Use of more
than one drug is a common practice, increases the complexity of such cases, and is associated with poorer
treatment outcomes.
• Of the treated cases reporting problem use of more than one drug, the rank order of additional drugs from
most common to least common remained the same between 1998 and 2000, namely: benzodiazepines,
followed by cannabis, opiates, ecstasy, cocaine and alcohol. In 2001 and 2002, the rank order changed. In
2002, cannabis replaced benzodiazepines as the most common drug, while cocaine moved up from fifth
most common to third most common. 
• For new cases treated, the pattern of additional drugs was linked to the main problem drug. For example,
where an opiate was the main problem drug the most common additional problem drugs were cannabis,
followed by benzodiazepines, other opiates and then cocaine. Information about the combinations of drugs
used is important in terms of individual clients’ care plans. 
• Injecting drug use was associated with opiates and, to a lesser extent, amphetamines and cocaine.
• Almost 18 per cent of all new cases treated were under 18 years of age, while only 3 per cent of cases
treated previously were in this young age group. Young teenagers initiated drug use with cannabis and
volatile inhalants. The use of opiates, ecstasy and amphetamines was commenced in mid to late teens. 
• The proportion of previously treated male cases remained stable, while there was an increase in the
proportion of new male cases treated. There were differences in type of drug used by new male and 
female cases, with very high proportions of males treated for cocaine and cannabis use compared to their
female counterparts. 
• The number of treated cases who reported leaving school early was higher among previously treated cases
(29%) than among new cases (21%). Employment levels among treated cases aged 16 to 64 years were
much lower than those in the general population: for example, 31 per cent of new cases treated were
employed and 24 per cent of previously treated cases were employed. For new cases, the highest rates of
employment were among those using drugs commonly associated with social events and the lowest rates of
employment were among those who used opiates and benzodiazepines; this observation, along with the
high rates of early school leaving, has important implications for the social and occupational reintegration of
opiate and benzodiazepine users. 
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Glossary of terms
• The median is the value at the mid-point in a sequence of numerical values ranged in ascending or
descending order. It is defined as the value above or below which half of the values lie. Unlike the mean
(average), the median is not influenced by extreme values (or outliers). For example, in the case of five drug
users aged 22, 23, 24, 24 and 46 years respectively, the median (middle value) is 24 years, whereas the mean
is 27.8 years. While both the median and the mean describe the central value of the data, the median is more
useful since the mean is influenced by the one older person in this example. 
• Incidence is a term used to describe the number of new cases of disease or events that develop among a
population during a specified time interval. For example, in 2001, ten opiate users living in a specific county
sought treatment for the first time. The incidence is the number of opiate cases divided by the population
living in the county (say 31,182 persons in this example) expressed per given number of the population, i.e.,
per 100, per 1,000, per 10,000, etc.
The calculation in this case is as follows: (10/31,182) x 10,000, which gives an incidence rate of 3.2 per
10,000 of the specific county population in 2001.
• Prevalence is a term used to describe the proportion of people in a population who have a disease or
condition at a specific point or period in time. For example, in 2001, ten opiate users living in a specific
county sought treatment for the first time, 20 opiate users returned to treatment in the year and five opiate
users continued in treatment from the previous year; in total there are 35 people treated for problem opiate
use in 2001. The prevalence is the total number of cases (35) divided by the population living in the county
(31,182 persons) expressed per given number of the population, i.e., per 100, per 1,000, per 10,000, etc. 
The calculation in this case is as follows: (35/31,182) x 10,000, which gives a prevalence rate of 11.2 per
10,000 of the specific county population in 2001.
• Epidemic disease levels are excess number of new cases among a specific population for that point and place
in time. An epidemic can also be called an outbreak. An excess number of cases is defined as a number
greater than two standard deviations above the normal expected for that point in time. 
• Endemic disease levels are numbers of new cases among a specific population that are within the normal
range for the time of year and place of residence. A normal number of cases is defined as a number within
two standard deviations of the normal expected for that point in time.
• Health boards and the Health Service Executive
• On 1 January 2005, the ten health boards managing the health services in Ireland were replaced by a single
entity, the Health Service Executive (HSE). The former health boards were responsible for health care
provision to populations in specific geographical areas. In the interest of continuity of care, the HSE has
maintained these ten areas for an interim period and called them HSE areas. The former Eastern Regional
Health Authority is known as the HSE Eastern Region for this interim period. 
• When the HSE has established itself and redeployed staff, health care will be provided through four HSE
regions and 32 local health offices. The local health offices will be based on the geographical boundaries of
the existing community care areas. In this paper we have presented the data by HSE area (that is, old health
board boundaries) and the four new HSE regions in order to reflect possible planning needs. 
• The table below presents the past health board structure, the present interim structure and the proposed
future regional structure.  
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Introduction
The National Drug Treatment Reporting System (NDTRS) is an epidemiological database on treated problem
drug use in Ireland. It was established in 1990 in the Greater Dublin Area and was extended in 1995 to cover
other areas of the country. The reporting system was originally developed in line with the Pompidou Group’s
Definitive Protocol (Hartnoll 1994) and subsequently refined in accordance with the Treatment Demand Indicator
Protocol (EMCDDA and Pompidou Group 2000). The NDTRS is co-ordinated by staff at the Drug Misuse Research
Division (DMRD) of the Health Research Board (HRB) on behalf of the Department of Health and Children. 
Drug treatment data are viewed as an indirect indicator of drug misuse as well as a direct indicator of demand
for treatment services. These data are used at national and European levels to provide information on the
characteristics of clients entering treatment, and on patterns of drug misuse, such as types of drug used and
consumption behaviours. They are ‘valuable from a public health perspective to assess needs, … and to plan
and evaluate services’ (EMCDDA 1998: 23). Information from the NDTRS is made available to service providers
and policy makers and is used to inform local and national drug policy and planning. For example, in 1996
NDTRS data were used to identify a number of local areas with problematic heroin use (Ministerial Task Force
1996). These areas were later designated as Local Drugs Task Force Areas and are continuing to provide
strategic responses to drug misuse in their communities. 
The monitoring role of the NDTRS is recognised by the Government in its document Building on Experience:
National Drugs Strategy 2001–2008. Data collection for the NDTRS is one of the actions identified and agreed
by Government for implementation by the former health boards: ‘All treatment providers should co-operate in
returning information on problem drug use to the DMRD of the HRB’ (Department of Tourism, Sport and
Recreation 2001: 118). 
Methods
Compliance with the NDTRS requires that one form be completed for each person who receives treatment for
problem drug use at each treatment centre in a calendar year. Service providers at drug treatment centres
throughout Ireland collect data on each individual treated for problem drug use. At national level, staff at the
DMRD of the HRB compile anonymous, aggregated data. 
For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to ameliorate the
psychological, medical or social state of individuals who seek help for their drug problems’. Clients who attend
Regional Health Authority Health boards HSE areas HSE regions 
Not applicable North Eastern Health Board HSE North Eastern Area 
HSE Dublin/North East RegionEastern Regional Health Northern Area Health Board HSE Northern Area
Authority (ERHA*) 
Eastern Regional Health East Coast Area Health Board HSE East Coast Area
Authority (ERHA)  
Eastern Regional Health South Western Area Health Board HSE South Western Area HSE Dublin/Mid-Leinster Region
Authority (ERHA)  
Not applicable Midland Health Board HSE Midland Area 
Not applicable South Eastern Health Board HSE South Eastern Area 
HSE Southern Region
Not applicable Southern Health Board HSE Southern Area 
Not applicable Mid-Western Health Board HSE Mid-Western Area 
Not applicable North Western Health Board HSE North Western Area HSE Western Region
Not applicable Western Health Board HSE Western Area 
*The ERHA is known as the HSE Eastern Region for the interim period.
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needle-exchange services are not included in this reporting system. Up to 2004, clients who reported alcohol as
their main problem drug were not included in this reporting system. Treatment options include one or more of
the following: medication (detoxification, methadone reduction and substitution programmes), addiction
counselling, group therapy, psychotherapy and/or life skills training. Treatment is provided in both residential
and non-residential settings (Table 1). In Ireland, data returns to the NDTRS for clients attending treatment
services during 2002 were provided by 175 treatment services: 154 non-residential and 21 residential. 
The main elements of the reporting system are defined as follows: 
All cases treated – describes individuals who receive treatment for problem drug use at each treatment
centre in a calendar year, and includes 
(a) Previously treated cases – describes individuals who were treated previously for problem drug use at
any treatment centre and have returned to treatment in the reporting year, and also those
individuals continuing in treatment from the preceding calendar year;
(b) New cases treated – describes individuals who have never been treated for problem drug use; 
(c) Status unknown – describes individuals whose status with respect to previous treatment for problem
drug use is not known.
In the case of the data for ‘previously treated cases’ there is a possibility of duplication in the database; for
example, where a person receives treatment at more than one centre. For those receiving methadone
maintenance or detoxification, this possibility is considered to be small since the introduction of the Misuse of
Drugs Regulations in 1998, whereby precautions are taken to ensure that methadone treatment is available
from one source only. 
The data presented in this paper provide a description of problem drug use in Ireland by health area of
residence. There were 35,683 cases treated in Ireland between 1998 and 2002. Of these, 33,391 (94%) cases
lived in Ireland, 47 (0.1%) cases did not live in Ireland, 77 (0.2%) cases had no fixed address, and 2,168 (6%)
cases had no place of residence recorded. The tables presenting data on service provision, treatment status and
place of residence are based on the 35,683 cases. The remainder of the tables and all the figures are based on
the 33,391 cases who lived and were treated in Ireland. 
Analysis
The analysis presented provides an outline of the following: service provision for problem drug use; numbers
treated for problem drug use; incidence and prevalence of treatment for problem drug use; main problem
drugs; additional problem drugs; risk behaviours; socio-demographic characteristics of cases; and relationship
between the main problem drug and selected characteristics. 
Service provision
The total number of drug treatment services available in Ireland and participating in the NDTRS increased
between 1998 and 2002 (Table 1). The largest increase was in outpatient treatment services. In the HSE Eastern
Region, counsellors employed by statutory services did not consistently return information on cases who
received counselling only, therefore there is an under-representation of cases in this region treated for use of
drugs other than opiates. There was a small increase in the number of residential treatment services. The
number of general practitioners participating in the NDTRS was very low. In 2002, there were 293 general
practitioners prescribing methadone treatment in Ireland, but only 28 (10%) provided returns to the NDTRS.
Cases who attended general practice may have differed from those who attended statutory treatment centres
and this may affect the generalisability of the findings presented in this paper. The prison service does not
participate in the NDTRS, although it does provide drug treatment services. There were inconsistencies in the
NDTRS data collection, data coding and data entry processes for data pertaining to the HSE Eastern Region up
to and including 2000. These have been rectified in the data presented in this paper; therefore, the numbers
presented in this paper for the years 1998 to 2000 differ from numbers presented in previous publications. 
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Numbers treated
Of the 35,683 cases treated for problem drug use in Ireland between 1998 and 2002, 9,415 (26%) were
treated for the first time. Overall, the number of cases previously treated and reported to the NDTRS increased
by 49 per cent between 1998 and 2002 (Table 2). The number of new cases treated and reported to the
NDTRS increased by 29 per cent during the reporting period. 
In relation to the prevention of and response to problem drug use, the geographical boundaries used by service
providers vary. In order to allow for different boundaries, selected data in this paper are presented by Health
Service Executive (HSE) region, by HSE area and by county of residence. 
Of the 35,683 cases treated in Ireland between 1998 and 2002, 33,391 (94%) cases lived in a specified HSE
region, 47 (0.1%) cases did not live in Ireland, 77 (0.2%) cases had no fixed address, and 2,168 (6%) cases had
no place of residence recorded (Table 3). 
Between 1998 and 2002, just under half (47%) of treated drug users lived in the HSE Dublin/Mid-Leinster
Region, while over one third lived in the HSE Dublin/North East Region (Table 4). The numbers of treated drug
users increased each year in all HSE regions except the Dublin/North East Region. In HSE Dublin/North East, the
total number of cases increased steadily up to 2001, but decreased by almost 10 per cent between 2001 and
2002. The number of previously treated cases followed a similar trend to that of all cases. Though small, the
numbers of new cases treated in the HSE Southern and HSE Western Regions increased considerably between
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Table 1   Number and type of services providing treatment for problem drug use and number of cases
treated (in brackets) in Ireland and reported to the NDTRS, 1998 to 2002
Drug services 1998 1999 2000 2001 2002 
Outpatient 83 (4566) 86 (4497) 105 (5583) 120 (6688) 124 (7270)
Residential 17 (1272) 16 (1005) 18 (796) 16 (725) 21 (798)
Low-threshold* 3 (182) 4 (284) 2 (280) 2 (216) 2 (149)
General practitioner 1 (24) 42 (413) 29 (274) 32 (271) 28 (371)
Treatment in prison 2 (4) 2 (7) 0 (0) 0 (0) 0 (0)
Not known 0 (0) 0 (0) 0 (0) 0 (0) 1 (8)
*Low-threshold services are services that provide low-dose methadone or drop-in facilities only.  
Table 2   Number (%) of cases treated in Ireland, by treatment status, reported to the NDTRS, 1998 to 2002
Treatment status 1998 1999 2000 2001 2002 
Number (%)
All cases 6048 6206 6933 7900 8596
Previously treated cases 4194 (69.3) 4421 (71.2) 4877 (70.3) 5663 (71.7) 6256 (72.8)
New cases 1626 (26.9) 1673 (27.0) 1941 (28.0) 2074 (26.3) 2101 (24.4)
Status unknown 228  (3.8) 112 (1.8) 115  (1.7) 163  (2.1) 239 (2.8)
Table 3   Number (%) of cases treated in Ireland, by place of residence and treatment status, reported to
the NDTRS, 1998 to 2002
Place of residence 1998 1999 2000 2001 2002 
Number (%)
All cases 6048 6206 6933 7900 8596
Specified HSE region 5590 (92.4) 5918 (95.4) 6611 (95.4) 7427 (94.0) 7845 (91.3)
Not resident in Ireland 10 (0.2) 12 (0.2) 9 (0.1) 7 (0.1) 9 (0.1)
No fixed abode 64 (1.1) 8 (0.1) 5 (0.1) 0 (0.0) 0 (0.0)
Dublin unknown 379 (6.3) 265 (4.3) 308 (4.4) 465 (5.9) 731 (8.5)
Unknown 5 (0.1) 3 (0.0) 0 (0.0) 1 (0.0) 11 (0.1)
1998 and 2002. The number of new cases treated in the HSE Dublin/North East was highest in 1999 and had
declined by 19 per cent by 2002, while the number of new cases treated in HSE Dublin/Mid-Leinster was
highest in 2000, and had declined by 28 per cent by 2002. 
Of the 33,391 treated cases living in Ireland, 120 cases lived in Wicklow but could not be assigned a specific
HSE area and were excluded from this analysis. As expected, the HSE South Western Area (Kildare and the south
western areas of Dublin and Wicklow) and HSE Northern Area (north Dublin) had the highest numbers of
treated cases (Table 5). The HSE Western Area (Galway, Mayo and Roscommon) and HSE North Western Area
(Donegal, Leitrim and Sligo) had the lowest numbers of treated cases. 
The numbers of cases living in the HSE East Coast Area (the coastal areas of Dublin and Wicklow), HSE Southern
Area (Cork and Kerry), HSE South Eastern Area (Carlow, Kilkenny, South Tipperary, Waterford and Wexford), 
HSE North Western and HSE Western Areas increased steadily between 1998 and 2000. In 2001, the numbers
treated in the HSE Midland Area (Laois, Longford and Westmeath) fell sharply and increased again in 2002,
indicating a possible lapse in participation rather than a true decrease in treatment seeking. Overall, the
numbers in the HSE South Western Area increased. In 2002, the numbers treated in the HSE North Eastern and
HSE Northern (Dublin) Areas decreased. According to staff in the HSE North Eastern Area, the reduction in
numbers reported to the NDTRS in 2002 was due to a reduction in returns to the reporting system rather than
an actual reduction in the demand for services. 
Numbers of previously treated cases are an indirect indicator of chronic drug use among the population living
in a geographical area. From 1998 to 2002, the number of previously treated cases who returned to, or
continued in, treatment and lived in the HSE South Western, HSE East Coast, HSE Midland, HSE Southern, HSE
South Eastern, HSE North Western and HSE Western Areas increased between 1998 and 2000. The number of
previously treated cases living in the HSE Mid-Western (Clare, Limerick and North Tipperary) and HSE Northern
(Dublin) Areas decreased by 10 per cent and 9 per cent respectively in 2002 compared to 2001. 
New cases seeking treatment are an indirect indicator of recent trends in problem drug use. The number of 
new cases treated who lived in the HSE Southern and HSE Western Regions increased between 1998 and 2002.
The number of new cases living in the HSE Northern (Dublin) and the HSE North Eastern Areas decreased by
approximately 15 per cent between 2001 and 2002. In the HSE South Western Area, the number of new cases
treated was highest in 2000 and had declined by 48 per cent by 2002. The reason for the decrease is the
decline in the number of new problem opiate users seeking treatment and living in certain areas of Dublin 
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Table 4   Number (%) of cases treated in Ireland, by HSE region of residence and by treatment status,
reported to the NDTRS, 1998 to 2002
HSE region of residence 1998 1999 2000 2001 2002
Number (%)
All cases 5590 5918 6611 7427 7845
HSE Dublin/North East 2235 (40.0) 2122 (35.9) 2325 (35.2) 2741 (36.9) 2481 (31.6)
HSE Dublin/Mid-Leinster 2693 (48.2) 3061 (51.7) 3123 (47.2) 3193 (43.0) 3560 (45.4)
HSE Southern 504 (9.0) 503 (8.5) 849 (12.8) 1064 (14.3) 1277 (16.3)
HSE Western 158 (2.8) 232 (3.9) 314 (4.7) 429 (5.8) 527 (6.7)
Previously treated cases 3907 4179 4647 5277 5666
HSE Dublin/North East 1643 (42.1) 1539 (36.8) 1817 (39.1) 2172 (41.2) 1983 (35.0)
HSE Dublin/Mid-Leinster 2020 (51.7) 2326 (55.7) 2390 (51.4) 2546 (48.2) 2986 (52.7)
HSE Southern 183 (4.7) 218 (5.2) 338 (7.3) 409 (7.8) 503 (8.9)
HSE Western 61 (1.6) 96 (2.3) 102 (2.2) 150 (2.8) 194 (3.4)
New cases 1477 1631 1855 1998 1975
HSE Dublin/North East 475 (32.2) 546 (33.5) 480 (25.9) 520 (26.0) 440 (22.3)
HSE Dublin/Mid-Leinster 610 (41.3) 678 (41.6) 679 (36.6) 600 (30.0) 488 (24.7)
HSE Southern 303 (20.5) 276 (16.9) 498 (26.8) 630 (31.5) 741 (37.5)
HSE Western 89 (6.0) 131 (8.0) 198 (10.7) 248 (12.4) 306 (15.5)
Status unknown 206 108 109 152 204
(Kelly et al. 2005). Although there were fluctuations, overall the numbers of new cases treated in the HSE East
Coast Area (the coastal areas of Dublin and Wicklow) almost doubled in 2001 when compared to the preceding
three years. The number of new cases living in the HSE Midland Area decreased by 30 per cent between 2000
and 2002; the reason for this is not clear. 
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Table 5   Number (%) of cases treated in Ireland, by HSE area of residence and by treatment status,
reported to the NDTRS, 1998 to 2002
HSE area of residence 1998 1999 2000 2001 2002
Number (%)
All cases 5574 5905 6592 7396 7804
Dublin/North East Region
Northern (Dublin) Area 2107 (37.8) 1967 (33.3) 2060 (31.3) 2347 (31.7) 2141 (27.4)
North Eastern Area 128 (2.3) 155 (2.6) 265 (4.0) 394 (5.3) 340 (4.4)
Dublin/Mid-Leinster Region
South Western Area (of Dublin 
and Wicklow and all of Kildare) 2255 (40.5) 2482 (42.0) 2467 (37.4) 2434 (32.9) 2688 (34.4)
East Coast Area (of Dublin and   
Wicklow) 326 (5.8) 425 (7.2) 469 (7.1) 591 (8.0) 647 (8.3)
Midland Area 96 (1.7) 141 (2.4) 168 (2.5) 137 (1.9) 184 (2.4)
Southern Region
Southern Area 303 (5.4) 308 (5.2) 504 (7.6) 630 (8.5) 715 (9.2)
South Eastern Area 201 (3.6) 195 (3.3) 345 (5.2) 434 (5.9) 562 (7.2)
Western Region
Mid-Western Area 96 (1.7) 160 (2.7) 204 (3.1) 249 (3.4) 245 (3.1)
North Western Area 48 (0.9) 40 (0.7) 80 (1.2) 101 (1.4) 132 (1.7)
Western Area 14 (0.3) 32 (0.5) 30 (0.5) 79 (1.1) 150 (1.9)
Previously treated cases 3898 4170 4637 5257 5635
Dublin/North East Region
Northern (Dublin) Area 1613 (41.4) 1486 (35.6) 1739 (37.5) 2022 (38.5) 1850 (32.8)
North Eastern Area 30 (0.8) 53 (1.3) 78 (1.7) 150 (2.9) 133 (2.4)
Dublin/Mid-Leinster Region
South Western Area (of Dublin
and Wicklow and all of Kildare) 1738 (44.6) 1929 (46.3) 1930 (41.6) 2017 (38.4) 2363 (41.9)
East Coast Area (of Dublin 
and Wicklow) 224 (5.7) 335 (8.0) 390 (8.4) 445 (8.5) 499 (8.9)
Midland Area 49 (1.3) 53 (1.3) 60 (1.3) 64 (1.2) 93 (1.7)
Southern Region
Southern Area 108 (2.8) 139 (3.3) 205 (4.4) 209 (4.0) 269 (4.8)
South Eastern Area 75 (1.9) 79 (1.9) 133 (2.9) 200 (3.8) 234 (4.2)
Western Region
Mid-Western Area 34 (0.9) 64 (1.5) 80 (1.7) 91 (1.7) 82 (1.5)
North Western Area 16 (0.4) 15 (0.4) 16 (0.3) 28 (0.5) 58 (1.0)
Western Area 11 (0.3) 17 (0.4) 6 (0.1) 31 (0.6) 54 (1.0)
New cases 1470 1627 1846 1987 1965
Dublin/North East Region
Northern (Dublin) Area 447 (30.4) 454 (27.9) 299 (16.2) 300 (15.1) 254 (12.9)
North Eastern Area 28 (1.9) 92 (5.7) 181 (9.8) 220 (11.1) 186 (9.5)
Dublin/Mid-Leinster Region
South Western Area (of Dublin 
and Wicklow and all of Kildare) 489 (33.3) 515 (31.7) 502 (27.2) 379 (19.1) 262 (14.0)
East Coast Area (of Dublin 
and Wicklow) 68 (4.6) 76 (4.7) 68 (3.7) 138 (6.9) 133 (6.8)
Midland Area 46 (3.1) 83 (5.1) 100 (5.4) 72 (3.6) 70 (3.6)
Southern Region
Southern Area 182 (12.4) 167 (10.3) 298 (16.1) 408 (20.5) 427 (21.7)
South Eastern Area 121 (8.2) 109 (6.7) 200 (10.8) 222 (11.2) 314 (16.0)
Western Region
Mid-Western Area 57 (3.9) 91 (5.6) 112 (6.1) 131 (6.6) 145 (7.4)
North Western Area 29 (2.0) 25 (1.5) 62 (3.4) 71 (3.6) 71 (3.6)
Western Area 3 (0.2) 15 (0.9) 24 (1.3) 46 (2.3) 90 (4.6)
Status unknown 206 108 109 152 204
Incidence and prevalence of treated drug use
The remainder of the analysis is based on 33,391 treated cases who lived in a specified HSE region and were
treated for problem drug use in Ireland between 1998 and 2002. 
In order to adjust for variation in population size in each HSE area and county, the actual incidence of treated
drug use in each area was calculated using the average number of new cases over the five-year period living in
each of the ten HSE areas and 26 counties; this average was divided by the population aged 15 to 64 years
living in the respective HSE areas and counties, using the census figures for 1998 and 2002 (Census 2003). 
Between 1998 and 2002, the incidence rate of treated problem drug use for the reporting period was highest in
the HSE South Western Area and the Northern (Dublin) Area, followed closely by the Southern, South Eastern
and North Eastern Areas (Figure 1). The Western Area had the lowest incidence, indicating one or more of the
following: lower drug use rates than in the rest of Ireland, lower access to or uptake of appropriate treatment
services, or lower participation in the NDTRS. 
The incidence rates of treated problem drug use were examined by county for the period 1998 to 2002 (Figure
2). The incidence rates were highest in Carlow, Dublin and Waterford (with over 100 cases per 100,000 of the
15 to 64 year old population) followed by Cork, Louth, Meath, Westmeath, Sligo, Tipperary and Limerick (with
between 50 and 99 cases per 100,000). Excluding Sligo, the incidence rates were lowest in western counties
(with between 10 and 19 cases per 100,000). 
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Figure 1   Average annual incidence of treated problem drug use among persons aged 15 to 64 years
living in Ireland, by HSE area, based on returns to the NDTRS per 100,000 of the population, 1998 to
2003 (Central Statistics Office 2003)
Figure 3 presents the incidence and prevalence of treated problem drug use from 1998 to 2002 among persons
aged between 15 and 64 years living in Ireland, expressed per 100,000 of the population. The prevalence of
treated problem drug use increased by 27 per cent between 1998 and 2002. The increased prevalence of
treated problem drug use indicates that this is a chronic health condition that requires repeated treatment over
time. The incidence of treated problem drug use increased by 24 per cent between 1998 and 2001, and
decreased by 6 per cent between 2001 and 2002. The decreased incidence observed in 2002 masks two
separate trends (not shown in Figure 3). The first trend is that the incidence of treated problem drug use in the
areas outside the HSE Eastern Region (Dublin, Kildare and Wicklow) almost trebled, from 24.8 per 100,000 of
the population in 1998 to 69.7 per 100,000 in 2002 (Long et al. 2004). The increase in incidence outside the
HSE Eastern Region may reflect a combination of an increase in the number of treatment services and an
increase in drug use. The second trend is a decrease in the incidence of treated problem drug use (specifically
opiates) in Dublin between 2000 and 2002 (Kelly et al. 2005). The decrease in the incidence of treated problem
opiate use may reflect a decrease in new opiate users in Dublin, saturation of the more vulnerable populations
in Dublin, a switch to other drugs (such as cocaine), a combination of these factors, or another factor not yet
identified. The most likely explanation is a decrease in new opiate users in certain areas of Dublin and, to a
lesser extent, a switch to other drugs by young people in Dublin. 
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Figure 2   Average annual incidence of treated problem drug use among persons aged 15 to 64 years
living in Ireland, by county, based on returns to the NDTRS per 100,000 of the population, 1998 to 2003
(Central Statistics Office 2003)
Main and additional problem drugs
The total number of cases who reported opiates, cannabis, ecstasy, benzodiazepines or cocaine as their main
problem drug increased steadily between 1998 and 2002 (Table 6). During the reporting period, an opiate was
the most frequently reported main problem drug, while cannabis was the second most frequently reported
main problem drug. The pattern of main problem drugs reported by cases previously treated was similar to that
reported by all cases, while the pattern reported by new cases was different. The number of new cases treated
who reported problem opiate use decreased by 21 per cent, from 922 in 1999 to 729 in 2002. The number of
new cases treated who reported problem cannabis use increased by 144 per cent, from 379 in 1998 to 925 in
2002. The numbers of new cases treated who reported cocaine as their main problem drug, though small,
increased consistently, from 78 in 1999 to 142 in 2002, indicating the early years of an epidemic. 
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Figure 3   Incidence and prevalence of treated problem drug use among persons aged between 15 and
64 years living and treated in Ireland, based on returns to the NDTRS per 100,000 population, 1998 to
2002 (Central Statistics Office 2003) 
The main problem drug reported by new cases treated between 1998 and 2002 was examined by health region
of residence (Table 7). The most commonly reported main problem drug for new cases living in each health
region varied: cases living in the HSE Dublin/North East and HSE Dublin/Mid-Leinster Regions reported opiates,
while cases living in the HSE Southern and HSE Western Regions reported cannabis. 
The proportion of cases treated who reported problems with more than one drug increased by 5 per cent, 
from 71 per cent in 1998 to 76 per cent in 2002 (Table 8). The same trend was noted among new and
previously treated cases. 
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Table 6   Main problem drug used by new cases treated in Ireland, by treatment status, reported to the
NDTRS, 1998 to 2002
Main problem drug 1998 1999 2000 2001 2002
Number (%)
All cases 5578 5918 6611 7427 7845
Opiates 4479 (80.3) 4770 (80.6) 4984 (75.4) 5589 (75.3) 5742 (73.2)
Cannabis 603 (10.8) 713 (12.0) 1062 (16.1) 1229 (16.5) 1477 (18.8)
Ecstasy 187 (3.4) 212 (3.6) 288 (4.4) 299 (4.0) 259 (3.3)
Benzodiazepines 89 (1.6) 47 (0.8) 96 (1.5) 103 (1.4) 95 (1.2)
Cocaine  78 (1.4) 55 (0.9) 74 (1.1) 91 (1.2) 142 (1.8)
Amphetamines 68 (1.2) 60 (1.0) 30 (0.5) 20 (0.3) 30 (0.4)
Volatile inhalants 34 (0.6) 32 (0.5) 39 (0.6) 39 (0.5) 46 (0.6)
Other substances 40 (0.7) 29 (0.5) 38 (0.6) 57 (0.8) 54 (0.7)
Previously treated cases 3899 4179 4647 5277 5666
Opiates  3508 (90.0) 3774 (90.3) 4081 (87.8) 4646 (88.0) 4897 (86.4)
Cannabis  176 (4.5) 233 (5.6) 345 (7.4) 392 (7.4) 488 (8.6)
Amphetamines  25 (0.6) 22 (0.5) 11 (0.2) 16 (0.3) 15 (0.3)
Ecstasy 60 (1.5) 63 (1.5) 75 (1.6) 97 (1.8) 91 (1.6)
Benzodiazepines  59 (1.5) 32 (0.8) 70 (1.5) 63 (1.2) 70 (1.2)
Cocaine  45 (1.2) 28 (0.7) 40 (0.9) 41 (0.8) 70 (1.2)
Volatile inhalants 9 (0.2) 11 (0.3) 9 (0.2) 2 (0.0) 9 (0.2)
Other substances 17 (0.4) 16 (0.4) 16 (0.3) 20 (0.4) 26 (0.5)
New cases 1474 1631 1855 1998 1975
Opiates  855 (58.0) 922 (56.5) 830 (44.7) 869 (43.5) 729 (36.9)
Cannabis  379 (25.7) 465 (28.5) 694 (37.4) 781 (39.1) 925 (46.8)
Ecstasy 113 (7.7) 141 (8.6) 206 (11.1) 197 (9.9) 162 (8.2)
Amphetamines  35 (2.4) 35 (2.1) 19 (1.0) 4 (0.2) 15 (0.8)
Cocaine  29 (2.0) 26 (1.6) 31 (1.7) 43 (2.2) 61 (3.1)
Benzodiazepines  22 (1.5) 11 (0.7) 24 (1.3) 35 (1.8) 25 (1.3)
Volatile inhalants 22 (1.5) 20 (1.2) 29 (1.6) 36 (1.8) 36 (1.8)
Other substances 19 (1.3) 11 (0.7) 22 (1.2) 33 (1.7) 22 (1.1)
Status unknown 205 108 109 152 204
Table 7   Main problem drug used by new cases treated in Ireland, by HSE region of residence, reported
to the NDTRS, 1998 to 2002
Main problem drug Dublin/North East Dublin/Mid-Leinster Southern Western
Number (%)
New cases 2461 3052 2448 972
Opiates 1592 (64.7) 2352 (77.1) 174 (7.1) 87 (9.0)
Cannabis 606 (24.6) 440 (14.4) 1601 (65.4) 597 (61.4)
Ecstasy 114 (4.6) 131 (4.3) 393 (16.1) 181 (18.6)
Cocaine 50 (2.0) 53 (1.7) 63 (2.6) 24 (2.5)
Volatile inhalants 36 (1.5) 20 (0.7) 53 (2.2) 34 (3.5)
Amphetamines 23 (0.9) 18 (0.6) 46 (1.9) 21 (2.2)
Benzodiazepines 22 (0.9) 25 (0.8) 58 (2.4) 12 (1.2)
Other substances 18 (0.7) 13 (0.4) 60 (2.5) 16 (1.6)
Between 1998 and 2002, the highest proportions reporting problems with more than one drug lived in the HSE
Southern and HSE Western Regions (Table 9). 
Of all cases treated between 1998 and 2002, 28 per cent reported problem use of one drug, 32 per cent
reported problem use of two drugs, 26 per cent reported problems with three drugs and 15 per cent reported
problems with four or more drugs (Table 10). A similar trend was noted among both new and previously
treated cases. 
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Table 8   Use of more than one drug by cases living and treated in Ireland, by treatment status, reported
to the NDTRS, 1998 to 2002
1998 1999 2000 2001 2002
Number (%)
All cases 5590 5918 6611 7427 7845
All cases who used more 
than one drug 3951 (70.7) 4123 (69.7) 4655 (70.4) 5533 (74.5) 5957 (75.9)
Previously treated cases 3907 4179 4647 5277 5666
Previously treated case who 
used more than one drug 2832 (72.5) 3012 (72.1) 3282 (70.6) 3976 (75.3) 4339 (76.6)
New cases 1477 1631 1855 1998 1975
New cases who used more 
than one drug 994 (67.3) 1042 (63.9) 1297 (69.9) 1450 (72.6) 1479 (74.9)
Status unknown cases 206 108 109 152 204
Status unknown cases who 
used more than one drug 125 (60.7) 69 (63.9) 76 (69.7) 107 (70.4) 139 (68.1)
Table 9   Use of more than one drug by new cases living and treated in Ireland, by HSE region of
residence, reported to the NDTRS, 1998 to 2002
Dublin/North East Dublin/Mid-Leinster Southern Western
Number (%)
All new cases 2461 3055 2448 972
New cases who used more 
than one drug 1530 (62.2) 1878 (61.5) 2091 (85.4) 763 (78.5)
Table 10   Number of problem drugs used by cases treated in Ireland, by treatment status, reported to
the NDTRS, 1998 to 2002
Number of problem drugs 1998 1999 2000 2001 2002
used Number (%)
All cases 5590 5918 6611 7427 7845
One drug 1638 (29.3) 1794 (30.3) 1956 (29.6) 1894 (25.5) 1888 (24.1)
Two drugs 1826 (32.7) 1737 (29.4) 2154 (32.6) 2544 (34.3) 2458 (31.3)
Three drugs 2011 (36.0) 1448 (24.5) 1426 (21.6) 1748 (23.5) 1962 (25.0)
Four drugs or more 115 (2.1) 939 (15.9) 1075 (16.3) 1241 (16.7) 1537 (19.6)
Previously treated cases 3907 4179 4647 5277 5666
One drug 1074 (27.5) 1166 (27.9) 1365 (29.4) 1301 (24.7) 1327 (23.4)
Two drugs 1306 (33.4) 1288 (30.8) 1530 (32.9) 1756 (33.3) 1731 (30.6)
Three drugs 1435 (36.7) 1061 (25.4) 1026 (22.1) 1276 (24.2) 1464 (25.8)
Four drugs or more 92 (2.4) 664 (15.9) 726 (15.6) 944 (17.9) 1144 (20.2)
New cases 1477 1631 1855 1998 1975
One drug 483 (32.7) 589 (36.1) 558 (30.1) 548 (27.4) 496 (25.1)
Two drugs 453 (30.7) 414 (25.4) 582 (31.4) 726 (36.3) 640 (32.4)
Three drugs 521 (35.3) 364 (22.3) 381 (20.5) 446 (22.3) 473 (23.9)
Four drugs or more 20 (1.4) 264 (16.2) 334 (18.0) 278 (13.9) 366 (18.5)
Status unknown 206 108 109 152 204
Between 1998 and 2002, a higher proportion of new cases treated in the HSE Southern Region reported problem
use of third and fourth drugs than the proportions in other regions (Table 11). Use of more than one drug is a
common practice, increases the complexity of such cases, and is associated with poorer treatment outcomes.
Of the treated cases reporting problem use of more than one drug, the rank order of the additional drugs from
most common to least common remained the same between 1998 and 2000, namely: benzodiazepines, followed
by cannabis, opiates, ecstasy, cocaine and alcohol (Table 12). In 2001 and 2002, the rank order changed. In
2002, cannabis replaced benzodiazepines as the most common drug, while cocaine moved up from fifth most
common to third most common. The pattern of drug use among previously treated cases was similar to that
among all cases. The rank order of additional problem drugs reported by new cases differed from that reported
by previously treated cases. In 1998, the rank order of the top four additional drugs reported by new cases was
cannabis, followed by ecstasy, benzodiazepines, and alcohol; by 2002 the rank order reported by new cases had
changed and the most common additional drugs were alcohol, followed by ecstasy, cannabis and cocaine. 
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Table 11   Number of problem drugs used by new cases treated in Ireland, by HSE region of residence,
reported to the NDTRS, 1998 to 2002
Number of problem drugs Dublin/North East Dublin/Mid-Leinster Southern Western
used Number (%)
New cases 2461 3055 2448 972
One drug 931 (37.8) 1177 (38.5) 357 (14.6) 209 (21.5)
Two drugs 749 (30.4) 989 (32.4) 718 (29.3) 359 (36.9)
Three drugs 507 (20.6) 631 (20.7) 802 (32.8) 245 (25.2)
Four drugs or more 274 (11.1) 258 (8.4) 571 (23.3) 159 (16.4)
Table 12   Additional problem drugs used by cases living and treated in Ireland, by treatment status,
reported to the NDTRS, 1998 to 2002
Additional problem drug(s) 1998 1999 2000 2001 2002
used* Number (%)
All cases who used 
additional drug(s) 3951 4123 4655 5533 5957
Benzodiazepines 1529 (38.7) 1694 (41.1) 1786 (38.4) 2277 (41.2) 2353 (39.5)
Cannabis 1335 (33.8) 1644 (39.9) 1743 (37.4) 2426 (43.8) 2694 (45.2)
Opiates 1308 (33.1) 1198 (29.1) 1162 (25.0) 1027 (18.6) 1154 (19.4)
Ecstasy 594 (15.0) 883 (21.4) 1098 (23.6) 1255 (22.7) 1293 (21.7)
Cocaine 412 (10.4) 748 (18.1) 884 (19.0) 1160 (21.0) 1569 (26.3)
Alcohol 406 (10.3) 457 (11.1) 724 (15.6) 908 (16.4) 1234 (20.7)
Amphetamines 311 (7.9) 383 (9.3) 409 (8.8) 302 (5.5) 306 (5.1)
Volatile inhalants 19 (0.5) 50 (1.2) 56 (1.2) 67 (1.2) 73 (1.2)
Other substances 279 (7.1) 393 (9.5) 369 (7.9) 341 (6.2) 310 (5.2)
Previously treated cases 
who used additional drug(s) 2832 3012 3282 3976 4339
Benzodiazepines  1299 (45.9) 1444 (47.9) 1576 (48.0) 2045 (51.4) 2110 (48.6)
Opiates  1115 (39.4) 1038 (34.5) 976 (29.7) 854 (21.5) 954 (22.0)
Cannabis  901 (31.8) 1170 (38.8) 1218 (37.1) 1855 (46.7) 2135 (49.2)
Cocaine  325 (11.5) 569 (18.9) 689 (21.0) 917 (23.1) 1235 (28.5)
Ecstasy  303 (10.7) 504 (16.7) 585 (17.8) 708 (17.8) 714 (16.5)
Alcohol  206 (7.3) 235 (7.8) 330 (10.1) 400 (10.1) 585 (13.5)
Amphetamines  127 (4.5) 156 (5.2) 163 (5.0) 125 (3.1) 132 (3.0)
Volatile inhalants  11 (0.4) 32 (1.1) 22 (0.7) 28 (0.7) 33 (0.8)
Other substances  165 (5.8) 254 (8.4) 201 (9.2) 208 (5.2) 189 (4.4)
New cases who used 
additional drug(s) 994 1042 1297 1450 1479
Cannabis  392 (39.4) 441 (42.3) 493 (38.0) 531 (36.6) 505 (34.1)
Ecstasy 256 (25.8) 362 (34.7) 493 (38.0) 513 (35.4) 548 (37.1)
Benzodiazepines  203 (20.4) 233 (22.4) 192 (14.8) 210 (14.5) 217 (14.5)
Alcohol  184 (18.5) 212 (20.3) 382 (29.5) 497 (34.3) 617 (41.7)
Opiates 161 (16.2) 144 (13.8) 176 (13.6) 157 (10.8) 182 (12.3)
Amphetamines  163 (16.4) 219 (21.0) 237 (18.3) 170 (11.7) 168 (11.4)
Cocaine  82 (8.2) 172 (16.5) 180 (13.9) 219 (15.1) 301 (20.4)
Volatile inhalants 8 (0.8) 18 (1.7) 31 (2.4) 38 (2.6) 39 (2.6)
Other substances  106 (10.7) 133 (12.8) 162 (12.5) 117 (8.1) 104 (7.0)
* By cases reporting use of one, two or three additional drugs.
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The types of additional problem drugs reported by new cases were the same in the HSE Dublin/North East and
HSE Dublin/Mid-Leinster Regions, but the rank order was different (Table 13). In the HSE Western and HSE
Southern Regions the types of additional drugs were the same but, once again, the rank order was different.
Among the top five additional drugs reported, there were three drugs that were common to all four regions:
cannabis, ecstasy and cocaine. 
The association between the main problem drug and additional drugs among new cases treated was examined
for the period 1998 to 2002 (Table 14). The pattern of additional drugs used was linked to the main problem
drug. For example, where an opiate was the main problem drug the most common additional problem drugs
were cannabis, followed by benzodiazepines, other opiates and then cocaine, whereas where cannabis was the
main problem drug the most common additional drugs were ecstasy, followed by alcohol and then
amphetamines. Information about the combinations of drugs used is important in terms of individual clients’
care plans.
Treatment provision
Given the complex nature of the problems associated with drug misuse, it is recognised that there is no single
treatment modality for problem drug use. Consequently, a broad range of services covering treatment and
rehabilitation is provided throughout the country. A question ascertaining the type of treatment provided on
admission to treatment was introduced to the NDTRS form in 1999. Of the 27,801 cases reported to the NDTRS
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Table 13   Additional problem drugs used by new cases living and treated in Ireland, by HSE region of
residence, reported to the NDTRS, 1998 to 2002
Additional problem Dublin/North East Dublin/Mid-Leinster Southern Western
drug(s) used* Number (%)
New cases who used 
additional drug(s) 1530 1878 2091 763
Cannabis 703 (45.9) 932 (49.6) 517 (24.7) 210 (27.5)
Ecstasy 431 (28.2) 411 (21.9) 992 (47.4) 338 (44.3)
Benzodiazepines 412 (26.9) 531 (28.3) 83 (4.0) 29 (3.8)
Opiates 320 (20.9) 388 (20.7) 76 (3.6) 36 (4.7)
Cocaine 258 (16.9) 307 (16.3) 276 (13.2) 113 (14.8)
Amphetamines 175 (11.4) 161 (8.6) 457 (21.9) 164 (21.5)
Alcohol  97 (6.3) 167 (8.9) 1326 (63.4) 302 (39.6)
Volatile inhalants 48 (3.1) 17 (0.9) 40 (1.9) 29 (3.8)
Other substances  139 (9.1) 110 (5.9) 268 (12.8) 105 (13.8)
* By new cases reporting use of one, two or three additional drugs.
Table 14   Main problem drug and associated additional drugs used by new cases (number and %) living
and treated in Ireland and reported to the NDTRS
Main problem drug used*
Benzo- Volatile
Opiates Cannabis Ecstasy Cocaine Amphetamines diazepines inhalants
2668 2398 719 167 93 78 65
Number (%)
Additional problem
drugs used†
Other opiates 653 (24.5) 93 (3.9) 22 (3.1) 26 (15.6) 4 (4.3) 13 (16.7) 1 (1.5)
Ecstasy 451 (16.9) 1536 (64.1) 80 (47.9) 57 (61.3) 13 (16.7) 9 (13.8)
Cocaine 512 (19.2) 303 (12.6) 110 (15.3) 18 (19.4) 4 (5.1)
Amphetamines 96 (3.6) 557 (23.2) 256 (35.6) 36 (21.6) 2 (2.6) 4 (6.2)
Other benzodiazepines 935 (35.0) 68 (2.8) 20 (2.8) 7 (4.2) 2 (2.2) 11 (14.1) 2 (3.1)
Other volatile inhalants 20 (0.7) 87 (3.6) 16 (2.2) 1 (0.6) 0 (0.0) 0 (0.0)    8 (12.3)
Other cannabis 1488 (55.8) 6 (0.3) 588 (81.8) 113 (67.7) 67 (72.0) 22 (28.2) 40 (61.5)
Alcohol 165 (6.2) 1241 (51.8) 300 (41.7) 48 (28.7) 19 (20.4) 45 (57.7) 39 (60.0)
* By specific drug, by new cases reporting more than one problem drug.
† By new cases reporting use of between one and three additional drugs.
who lived in Ireland and received treatment between 1999 and 2002, 27,412 had an initial treatment recorded
and 389 had no treatment recorded. Of the 27,412 cases for whom initial treatment was documented, 52 per
cent (14,334) received counselling or advice, 8 per cent (2,198) had medication-free therapy, 4 per cent (1,061)
attended a social or occupational rehabilitation programme, 14 per cent (3,847) commenced medically assisted
detoxification and 52 per cent (14,138) commenced methadone maintenance at their first treatment visit. Of the
27,412 cases for whom initial treatment was documented, 8,499 (31%) had more than one type of initial
treatment, therefore the total number of treatments is greater than the number of cases.
Risk behaviours
Between 1998 and 2002, 50 per cent of treated drug users had commenced illicit use of drugs before they
were 15 years old (Table 15). Of those who ever injected illicit drugs, 50 per cent started injecting before they
were 19 years old. With respect to the ages at which illicit use of drugs commenced and ages at which illicit
injecting of drugs commenced, both new and previously treated cases reported similar age ranges. 
Between 1998 and 2002, the number of cases previously treated who reported ever injecting increased by 41
per cent, while the number of new cases who reported ever injecting decreased by 24 per cent. During the
same time period, the number of injectors previously treated who reported ever sharing injecting equipment
increased by 63 per cent, while the number of new injectors who reported the same practice decreased by 21
per cent. 
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Table 15   Risk behaviours reported by all cases living and treated in Ireland, by treatment status,
reported to the NDTRS, 1998 to 2002
Injecting and sharing status 1998 1999 2000 2001 2002
All cases – 
Number injector status known 5284 5755 6470 7278 7666
Median age (range)* 
started use, in years 15 (11-22) 15 (11-22) 15 (11-21) 15 (11-21) 15 (11-21)
Median age (range)* 
started injecting, in years 19 (15-27) 19 (14-28) 19 (14-28) 19 (14-29) 19 (15-28)
Number (%) ever injected 3468 (65.6) 3888 (67.6) 4193 (64.8) 4383 (60.2) 4510 (58.8)
Of whom:†
‘ever shared’ 2043 (58.9) 2490 (64.0) 2815 (67.1) 3035 (69.2) 3087 (68.4)
‘currently injecting’  1833 (52.9) 1749 (45.0) 1770 (42.2) 1787 (40.8) 1619 (35.9)
‘currently sharing’  480 (13.8) 465 (12.0) 439 (10.5) 361 (8.2) 252 (5.6)
Previously treated cases –
Number injector status known 3740 4083 4564 5192 5567
Median age (range)* 
started use, in years 15 (11-22) 15 (11-22) 15 (11-21) 15 (11-21) 14 (11-21)
Median age (range)* 
started injecting, in years 19 (15-27) 18 (14-27) 19 (14-28) 19 (14-28) 19 (15-28)
Number (%) ever injected 2871 (76.8) 3207 (78.5) 3591 (78.7) 3852 (74.2) 4055 (72.8)
Of whom:†
‘ever shared’ 1762 (61.4) 2142 (66.8) 2514 (70.0) 2776 (72.1) 2877 (70.9)
‘currently injecting’  1455 (50.7) 1373 (42.8) 1454 (40.5) 1465 (38.0) 1363 (33.6)
‘currently sharing’  379 (13.2) 356 (11.1) 361 (10.1) 276 (7.2) 201 (5.0)
New cases – 
Number injector status known 1415 1583 1813 1960 1925
Median age (range)* 
started use, in years 15 (12-21) 15 (12-22) 15 (11-22) 15 (11-23) 15 (11-23)
Median age (range)* 
started injecting, in years 19 (15-28) 19 (15-30) 19 (15-31) 19 (15-32) 19 (15-32)
Number (%) ever injected 514 (36.3) 624 (39.4) 543 (30.0) 476 (24.3) 391 (20.3)
Of whom:†
‘ever shared’ 238 (46.3) 320 (51.3) 278 (51.2) 241 (50.6) 187 (47.8)
‘currently injecting’  327 (63.6) 345 (55.3) 287 (52.9) 282 (59.2) 223 (57.0)
‘currently sharing’  88 (17.1) 105 (16.8) 74 (13.6) 80 (16.8) 48 (12.3)
* Age range presented is the 5th to 95th percentile (90% of all cases are within this age range).
† From the data presented in this table, it is not possible to ascertain the exact percentage of injectors with each risk factor of interest as
a not all known injectors had completed the subsequent injecting questions. 
Between 1998 and 2002, the median age at which new cases commenced illicit use of drugs was similar across
all HSE regions (Table 16). In the HSE Dublin/North East and the HSE Dublin/Mid-Leinster Regions, the median
age at which new cases commenced injecting drug use was lower than that in the HSE Southern and HSE
Western Regions. During the reporting period, the proportions of new cases treated who reported ever injecting
illicit drugs was much lower in the HSE Southern and HSE Western Regions than in the HSE Dublin/North East
and the HSE Dublin/Mid-Leinster Regions. 
Socio-demographic characteristics
The median age of cases previously treated increased by two years between 1998 and 2002, while the median
age of new cases increased by one year (Table 17). Almost 18 per cent of all new cases were under 18 years of
age, while only 3 per cent of cases previously treated were in this young age group. The proportion of
previously treated male cases remained stable, while there was an increase in the proportion of new male cases
treated. The number of cases who reported leaving school early was higher among previously treated cases
(29%) than among new cases (21%). The numbers of both new and previously treated cases who were still in
school increased steadily between 1998 and 2002. Employment levels among treated drug users aged 16 to 64
years were much lower than those in the general population: for example, 31 per cent of new cases were
employed and 24 per cent of previously treated cases were employed. 
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Table 16   Risk behaviours reported by new cases living and treated in Ireland, by HSE region of
residence, reported to the NDTRS, 1998 to 2002
New cases Dublin/North East Dublin/Mid-Leinster Southern Western
Number injector 
status known 2402 2976 2395 923
Median age (range)* started 
use, in years 15 (11-23) 15 (11-21) 15 (12-24) 15 (11-21)
Median age (range)* started 
injecting, in years 19 (15-31) 19 (15-28) 21 (16-35) 22 (15-30)
Number (%) ever injected 981 (40.8) 1393 (46.8) 118 (4.9) 56 (6.1)
Of whom:†
‘ever shared’ 531 (54.1) 671 (48.2) 43 (36.4) 19 (33.9)
‘currently injecting’  632 (64.4) 769 (55.2) 40 (33.9) 23 (41.1)
‘currently sharing’  182 (18.6) 198 (14.2) 12 (10.2) 3   (5.4)
* Age range presented is the 5th to 95th percentile (90% of all cases are within this age range).
† From the data presented in this table, it is not possible to ascertain the exact percentage of injectors with each risk factor of interest as
not all known injectors had completed the subsequent injecting questions. 
The socio-economic characteristics of new cases treated were examined by health region of residence for the
period 1998 to 2002 (Table 18). Higher proportions of treated drug users were under 18 years and male in the
HSE Western and HSE Southern Regions than in the other two health regions. In the HSE Western and HSE
Southern Regions, new cases under 18 years were more likely to be in school than in the other two regions. 
In the HSE Dublin/Mid-Leinster Region higher proportions had left school early than in the HSE Dublin/North
East, the HSE Southern and the HSE Western Regions. 
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Table 17   Socio-economic characteristics of cases living and treated in Ireland, by treatment status,
reported to the NDTRS, 1998 to 2002
Characteristics* 1998 1999 2000 2001 2002
Number (%)
All cases* 5590 5918 6611 7427 7845
Median age (range)† in years 23.6 (17.1-37.8) 24.2 (17.7-38.2) 24.8 (17.5-39.0) 25.2 (17.6-39.9) 25.8 (17.2-40.7)
Number (%) under 18 years 
of age 501 (9.0) 365 (6.2) 436 (6.6) 479 (6.5) 551 (7.1)
Number (%) of males 3856 (70.3) 4073 (69.0) 4638 (70.4) 5204 (70.8) 5306 (71.0)
Number (%) living with 
parents/family 3605 (65.2) 3652 (62.0) 4004 (61.3) 4352 (61.8) 4480 (59.7)
Number (%) homeless § § § 216 (3.2) 207 (3.0)
Number (%) of early 
school leavers‡ 1241 (27.5) 1285 (26.7) 1585 (28.2) 1726 (27.4) 1690 (25.3)
Number (%) still in school 151 (11.9) 146 (13.6) 192 (18.3) 208 (19.6) 335 (30.8)
Number (%) aged 16 to 64 
years employed 1072 (20.5) 1514 (26.9) 1815 (29.1) 1928 (27.8) 1890 (25.8)
Previously treated cases* 3907 4179 4647 5277 5666
Median age (range)† in years 24.6 (18.1-38.8) 25.3 (18.7-38.9) 25.8 (19.0-39.3) 26.2 (19.3-40.2) 26.7 (19.4-41.3)
Number (%) under 18 
years of age 180 (4.6) 113 (2.7) 122 (2.6) 120 (2.3) 135 (2.4)
Number (%) of males 2631 (68.6) 2799 (67.1) 3131 (67.6) 3611 (69.1) 3680 (68.5)
Number (%) living with 
parents/family 2473 (64.1) 2460 (59.1) 2691 (58.5) 2975 (59.6) 3068 (56.8)
Number (%) homeless § § § 150 (3.2) 146 (2.9)
Number (%) of early 
school leavers‡ 952 (28.9) 986 (28.2) 1285 (31.1) 1370 (29.5) 1389 (27.5)
Number (%) still in school 35 (5.5) 25 (5.1) 31 (7.0) 34 (8.8) 57 (14.5)
Number (%) aged 16 to 64 
years employed 646 (17.4) 992 (24.9) 1211 (27.3) 1294 (25.9) 1342 (25.0)
New cases* 1477 1631 1855 1998 1975
Median age (range)† 
in years 21.1 (16.2-33.6) 21.8 (16.3-35.4) 22.0 (16.0-37.0) 22.2 (15.9-37.3) 22.2 (15.4-38.1)
Number (%) under 18 
years of age 293 (19.9) 240 (14.8) 307 (16.6) 350 (17.6) 407 (20.7)
Number (%) of males 1087 (74.6) 1191 (73.2) 1419 (76.8) 1474 (74.5) 1473 (77.0)
Number (%) living with 
parents/family 1062 (72.6) 1128 (69.4) 1257 (68.6) 1323 (68.5) 1310 (67.8)
Number (%) homeless § § § 51 (2.7) 47 (2.5)
Number (%) of early 
school leavers‡ 269 (23.2) 284 (22.6) 285 (20.1) 331 (21.1) 273 (18.2)
Number (%) still in school 104 (18.2) 117 (21.0) 158 (27.0) 171 (26.1) 273 (40.6)
Number (%) aged 16 to 64 
years employed 371 (27.2) 500 (32.5) 580 (33.8) 598 (32.9) 507 (28.6)
* It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all forms had
complete data. 
† Age range presented is the 5th to 95th percentile (90% of all cases are within this age range).
‡ Left school before the age of 15 years.
§ Not available.
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Table 18   Socio-economic characteristics of new cases living and treated in Ireland, by HSE region of
residence, reported to the NDTRS, 1998 to 2002
Characteristics* Dublin/North East Dublin/Mid-Leinster Southern Western
Number (%)
New cases* 2461 3055 2448 972
Median age (range)† in years 22.2 (15.6-35.8) 22.2 (16.8-35.5) 21.3 (15.5-38.8) 21.2 (15.5-35.8)
Number (%) under 18 
years of age 450 (18.4) 364 (12.0) 551 (22.5) 232 (24.0)
Number (%) of males 1755 (72.9) 2198 (72.6) 1938 (79.7) 753 (78.5)
Number (%) living with 
parents/family 1707 (70.4) 2142 (71.5) 1579 (65.4) 652 (68.5)
Number (%) of early 
school leavers‡ 458 (24.5) 546 (22.2) 337 (17.8) 101 (14.9)
Number (%) still in school 223 (28.7) 137 (15.4) 308 (32.1) 155 (37.2)
Number (%) aged 16 to 64 
years employed 688 (30.9) 801 (27.9) 814 (36.4) 253 (29.0)
* It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all forms had 
a complete data. 
† Age range presented is the 5th to 95th percentile (90% of all cases are within this age range).
‡ Left school before the age of 15 years.
Figure 4   The three most common main problem drugs, by HSE area, for new cases living and treated in
Ireland, reported to the NDTRS, 1998 to 2002
Relationship between main problem drug and selected characteristics
In order to highlight important relationships, the main problem drug reported by new cases was examined by
selected socio-demographic and economic characteristics. Figure 4 presents the three most common main
problem drugs reported by new cases treated in each HSE area. The types of drugs reported differed by Health
Service Executive (HSE) area. In the HSE Northern (Dublin), HSE East Coast, HSE South Western, HSE North
Eastern and HSE Midland Areas, opiates and cannabis were the most common main problem drugs reported by
new cases treated. In the HSE Southern, HSE South Eastern and HSE Western Areas, cannabis and ecstasy were
the most common main problem drugs reported by new cases. This may reflect either the types of drug used or
the types of treatment service provided in the area, or a combination of both factors. 
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Figures 5a and 5b present the age at which new cases living and treated in Ireland commenced use of their
main problem drug for the period 1998 to 2002. It is clear that young teenagers initiated drug use with
cannabis and, to a lesser extent, ecstasy and volatile inhalants. The majority commenced use of opiates and
amphetamines in their mid to late teens. The number reporting benzodiazepines and cocaine as their main
problem drug was small, but these are more common as additional drugs. Benzodiazepines and cocaine were
also more common among older and previously treated problem drug users.
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Figure 5a   Age commenced use of main problem drug for new cases living and treated in Ireland,
reported to the NDTRS, 1998 to 2002
Figure 5b   Age commenced use of main problem drug (excluding opiates and cannabis) for new cases
living and treated in Ireland, reported to the NDTRS, 1998 to 2002
Figures 6a and 6b present the age at which new cases sought treatment in Ireland, by the main problem drug,
for the period 1998 to 2002. Although the numbers using volatile inhalants are small, it is the main problem
drug for a very young client group. It is clear that cannabis and ecstasy are the drugs that young people seek
treatment for in the late teens, while the majority of opiate users seek treatment in their early twenties. Taken
together, Figures 5a and 5b and Figures 6a and 6b present the delay between initiation of the main problem
drug (such as cannabis and opiates) and seeking treatment for problem drug use. 
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Figure 6a   Age attended first treatment, by main problem drug, for new cases living and treated in
Ireland, reported to the NDTRS, 1998 to 2002
Figure 6b   Age attended first treatment, by main problem drug (excluding opiates and cannabis), for
new cases living and treated in Ireland, reported to the NDTRS, 1998 to 2002
Figure 7 presents the gender of new cases who sought treatment in Ireland, by the main problem drug, for the
period 1998 to 2002. The proportion of males treated for cocaine, cannabis and amphetamine use was very
high compared to that of their female counterparts. Although the proportion of males treated for opiate and
benzodiazepine use was higher than the proportion of females, the gender difference pertaining to the use of
these drugs was not as striking as that pertaining to cocaine, cannabis, amphetamine and ecstasy use. 
Figure 8 presents the employment status of new cases who sought treatment, by the main problem drug, for
the period 1998 to 2002. The highest rates of employment were among those who used drugs commonly
associated with social events, and the lowest rates of employment were among those who used opiates and
benzodiazepines. This has important implications for the social and occupational reintegration of opiate and
benzodiazepine users. 
Figure 9 presents the route of administration of the main problem drug reported by new cases who sought
treatment between 1998 and 2002. Injecting drug use was associated with opiates and, to a lesser extent, with
amphetamines and cocaine. Of the new cases reporting benzodiazepines as their main problem drug, none
reported injecting the drug. 
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Figure 7   Main problem drug, by gender, for new cases living and treated in Ireland, reported to the
NDTRS, 1998 to 2002
Figure 9   Route of administration of selected main problem drugs for new cases living and treated in
Ireland, reported to the NDTRS, 1998 to 2002
Figure 8   Main problem drug, by regular employment, for new cases aged between 16 and 64 years
living and treated in Ireland, reported to the NDTRS, 1998 to 2002
Trends in treated problem drug use in Ireland, 1998 to 2002
Drug Misuse Research Division 23
Conclusions
The increased prevalence of treated problem drug use indicates that this is a chronic health condition that
requires repeated treatment over time. The decreased incidence observed in 2002 masks two separate trends.
The first trend is that the incidence of treated problem drug use in the area outside the HSE Eastern Region
almost trebled, from 24.8 per 100,000 of the population in 1998 to 69.7 per 100,000 in 2002 (Long et al.
2004). The second trend is a decrease in the incidence of treated problem drug use (specifically opiates) in
Dublin between 2000 and 2002 (Kelly et al. 2005). The decrease in the incidence of treated problem opiate 
use may reflect a decrease in new opiate users in Dublin, saturation of the more vulnerable populations in
Dublin, a switch to other drugs (such as cocaine), a combination of these factors, or another factor not yet
identified. The most common main problem drugs reported by cases treated are opiates and cannabis. In 
2002, three-quarters of cases reported use of more than one drug as a common practice, which increases the
complexity of such cases and is associated with poorer treatment outcomes. The pattern of additional drugs
used was linked to the main problem drug. For example, where an opiate was the main problem drug the most
common additional problem drugs were cannabis, followed by benzodiazepines and cocaine. Information about
the combinations of drugs used is important in terms of individual clients’ care plans. In general, problem drug
users are young, male, have low levels of education and are unlikely to be employed, indicating the importance
of personal development, educational and employment opportunities as part of the drug treatment and
reintegration process. 
The main problem drug reported by new cases was examined by selected socio-demographic and drug-using
characteristics and some important relationships were identified. The types of drug used by new cases differed
by HSE area. In the HSE Northern (Dublin), HSE East Coast, HSE South Western, HSE North Eastern and HSE
Midland Areas, both opiates and cannabis were the more common main problem drugs reported by new cases
treated. In the HSE Southern, HSE South Eastern and HSE Western Areas, cannabis and ecstasy were the more
common main problem drugs reported by new cases. This may reflect the types of drug used or the types of
treatment service provided in the area, or a combination of both factors. Young teenagers initiated drug use
with cannabis and volatile inhalants. The use of opiates, ecstasy and amphetamines was commenced in mid to
late teens. There were differences in type of drug used by males and females, with very high proportions of
males treated for cocaine and cannabis use compared to their female counterparts. The highest rates of
employment were among those using drugs commonly associated with social events and the lowest rates of
employment were among those who used opiates and benzodiazepines; this observation, along with the high
rates of early school leaving, has important implications for the social and occupational reintegration of opiate
and benzodiazepine users. Injecting drug use was associated with opiates and to a lesser extent with
amphetamines and cocaine.
These treatment data are important in guiding future drug policy and planning. They will provide baseline data
for the HSE regions and regional drugs task forces. The increasing importance of alcohol as an additional
problem drug and the overlap between problem alcohol and drug use point to the need for an integrated
approach to the management of problem substance use. 
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